November 2021 in “CRC Press eBooks” This article reviews various congenital and acquired hair shaft disorders, examining their characteristics and potential links to wider health conditions, but does not present any new clinical results.
11 citations
,
June 2020 in “Russian Open Medical Journal” This study found a higher frequency of below normal ferritin and serum iron levels in women with melasma compared to controls, suggesting a possible association with melasma.
6 citations
,
April 2019 in “Russkij žurnal detskoj nevrologii” This study found that neuroendocrine and reproductive disorders were most commonly reported in women with epilepsy taking valproic acid, while newer antiepileptic drugs resulted in more favorable outcomes.
3 citations
,
December 2022 in “Russian Journal of General Chemistry” In this experiment, CoCr2O4 spinel chromite nanocatalysts showed high catalytic efficiency with a 95.6% yield in producing 4-substituted diaminopyrimidine oxides from 2,6-diamino-4-chloropyrimidine N-oxide, while maintaining stable performance over five reuse cycles.
2 citations
,
June 2016 in “Russian Journal of Skin and Venereal Diseases” This study reported a decrease in zinc and iron levels in the blood and an increase in certain trace elements in hair among patients with alopecia areata compared to healthy individuals.
1 citations
,
April 2024 in “Russian Journal of Clinical Dermatology and Venereology” In this study, children with alopecia areata and comorbid atopic diseases experienced an earlier onset of the condition and were more likely to develop severe forms compared to those without atopy.
1 citations
,
February 2023 in “Russian Journal of Bioorganic Chemistry” In an animal study, researchers observed that a newly synthesized deoxycholic acid derivative showed similar prostate protection effects to finasteride in Wistar rats while being less toxic.
1 citations
,
April 2015 in “Russkij žurnal detskoj nevrologii” This study found that young women with epilepsy experienced various neuroendocrinal and reproductive side effects, with valproic acid showing the highest risk for teratogenic effects and associated disorders.
September 2026 in “Russian Journal of Skin and Venereal Diseases” In this study, photodynamic therapy combined with platelet-rich plasma showed potential for greater efficacy than photodynamic therapy alone in treating androgenic alopecia, with both approaches improving hair density without serious side effects.
August 2026 in “Russian Journal of Skin and Venereal Diseases” In this prospective study, combining photodynamic therapy with PRP therapy significantly improved hair growth, quality of hair, and quality of life in women with acute telogen effluvium, compared to using each therapy alone.
June 2026 in “Russian Journal of Skin and Venereal Diseases” This study evaluated salmon-derived exosomes combined with microneedling as a treatment for androgenetic alopecia, reporting significant improvements in hair density, follicular health, and scalp microenvironment, with no serious adverse events observed in the 20 patients after 12 weeks.
May 2026 in “Russian Journal of Skin and Venereal Diseases” This study found that salmon tissue-derived exosomes showed significantly greater improvements in hair density and other parameters compared to platelet-rich plasma in patients with mild to moderate androgenetic alopecia.
May 2026 in “Russian Journal of Skin and Venereal Diseases” In this study, researchers observed a high prevalence of ferritin and vitamin D deficiency in women with acute telogen effluvium, highlighting the importance of laboratory screening for these deficiencies, while also noting a correlation between ferritin levels and hair loss severity.
April 2026 in “Russian Journal of Skin and Venereal Diseases” This review reports that hyperandrogenic conditions in women, which affect skin and overall well-being, lack dedicated treatment guidelines, presenting challenges in standardizing care.
December 2025 in “Russian Journal of Skin and Venereal Diseases” This study found that in patients with non-cicatricial alopecia, hair follicles and their sheaths were thinner compared to controls, especially in cases of alopecia areata and telogen effluvium, with notable thinning beginning in the subcutaneous fat tissue.
December 2025 in “Russian Journal of Skin and Venereal Diseases” This review suggests that mesenchymal stem cells and exosomes may be effective in regenerating hair follicles for treating androgenic alopecia, but more research on their mechanisms and efficacy is necessary.
December 2025 in “Russian Journal of Skin and Venereal Diseases” In this study, researchers found that patients with non-scar alopecia exhibited thinner hair sacs and root sheaths compared to a control group, with significant thinning observed in cases of alopecia areata.
November 2025 in “Russian Journal of Oncology” This review examines recent research on optimizing the structures of steroidal inhibitors for key steroidogenic enzymes used as cancer treatments, reporting on 209 new compounds with preclinical data that suggest structural modifications hold promise for developing new antineoplastic agents.
July 2025 in “Russian Journal of Skin and Venereal Diseases” This article discusses the characteristics, diagnosis, and clinical presentation of different variants of lichen planopilaris on the scalp, with emphasis on cicatricial alopecia and the importance of clinical and trichoscopic monitoring; it presents no new clinical results.
July 2025 in “Russian Journal of Skin and Venereal Diseases” In this article, two patients with mild to moderate androgenetic alopecia showed improved hair density and reduced vellus hairs after treatment with exosome-derived solutions from salmon tissues, suggesting potential benefits of this approach.
July 2025 in “Russian Journal of Transplantology and Artificial Organs” This research highlights advancements in reconstructive surgery for managing scars, emphasizing the importance of combined surgical and nonsurgical interventions like platelet-rich plasma and stem cell therapy to prevent and treat thick scar tissue while enhancing functionality and aesthetic outcomes.
July 2025 in “Russian Journal of Clinical Dermatology and Venereology” This paper highlights the emerging trend of treating androgenic alopecia with botulinum toxin, despite insufficient scientific evidence supporting its effectiveness.
July 2025 in “Russian Journal of Clinical Dermatology and Venereology” In this case report, researchers observed that two sisters with congenital immune disorders experienced partial hair regrowth while receiving tofacitinib for severe alopecia areata, highlighting the need for careful clinical and laboratory monitoring due to potential infection risks associated with JAK inhibitor therapy.
July 2025 in “Russian Journal of Clinical Dermatology and Venereology” This review discusses the multifactorial nature and treatment of alopecia areata, highlighting its prevalence among adolescents and the necessity for comprehensive diagnostic and therapeutic approaches, but reports no new empirical findings.
April 2025 in “Russian Pediatric Journal” This review discusses the application of PRP therapy in pediatric settings and highlights the current lack of sufficient data for its widespread clinical use.
April 2024 in “Russian Journal of Preventive Medicine” This review discusses how skin changes like acanthosis nigricans and psoriasis can indicate metabolic syndrome components such as insulin resistance and dyslipidemia, suggesting a potential role for early diagnosis and treatment in reducing cardiovascular risks associated with the syndrome.
October 2023 in “Russian Journal of Veterinary Pathology” This source reviews existing studies on treating canine noninflammatory alopecia, identifying microneedling and oral administration of certain drugs as optimal methods with fewer side effects, while noting that other treatments like mitotane and minoxidil cause serious side effects, limiting their future use.
September 2023 in “Russian Journal of Skin and Venereal Diseases” This study reported a rare case of necrobiosis lipoidica occurring on the scalp, leading to scarring alopecia, and highlighted a positive response to glucocorticoid therapy by reducing the brightness and growth of plaques over one month.
April 2023 in “Russian Journal of Clinical Dermatology and Venereology” This study found that after a 4-month comprehensive therapy course, 90.5% of patients with androgenetic alopecia and telogen effluvium showed hair condition improvement, highlighting the potential benefits of adjuvant proteoglycan replacement therapy in these conditions.
June 2026 in “The Russian Archives of Internal Medicine” This case report detailed a 38-year-old woman with thallium intoxication, who initially presented with polyneuropathy and alopecia. The diagnosis was confirmed by toxicology, and treatment with potassium hexacyanoferrate led to full recovery, underscoring the importance of early diagnosis and treatment in toxic polyneuropathies.